{"id":160356,"date":"2020-02-27T00:00:00","date_gmt":"2020-02-27T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/products\/research-reports\/report\/mpayus0001-digital-multichannel-payer-marketing-us-2020\/"},"modified":"2026-03-31T14:33:48","modified_gmt":"2026-03-31T14:33:48","slug":"mpayus0001-digital-multichannel-payer-marketing-us-2020","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/mpayus0001-digital-multichannel-payer-marketing-us-2020\/","title":{"rendered":"Multichannel Payer Marketing | US | 2020"},"content":{"rendered":"<p><strong>Multichannel Payer Marketing 2020<\/strong> is aimed to understand how and where U.S. payers obtain information for formulary decision-making, specifically using digital channels in addition to traditional methods, pinpointing unmet needs and determining how pharmas can better engage these key customers.<\/p>\n<p><strong>Research themes include: <\/strong><\/p>\n<ul>\n<li>In-depth look at <strong>U.S. payer\u2019s activity &#038; preferences<\/strong> to inform multichannel engagement strategies\u00a0<\/li>\n<li>Understanding of <strong>how payer\u2019s behaviors change by where they work or practice<\/strong>; differences will be available by those who sit on their P&#038;T committee within hospitals, IDNs, MCOs or PBMs*.\n<ul>\n<li>Due to recent payer consolidations, we may be unable to have a readable base size of PBMs in our 2019 research, this group may become a subset of MCOs (i.e. Express scripts and Cigna merger, CVS health and Aetna merger, etc.)<\/li>\n<\/ul>\n<\/li>\n<li>Identify how and where<strong> pharmas can best engage with payers online<\/strong>\n<ul>\n<li>Considerations for building a payer portal vs. expanding on HCP focused websites for payers<\/li>\n<li>Tools and materials pharmas can provide based on payer needs and interests<\/li>\n<li>Sponsorship\/advertising opportunities on non-pharma websites geared towards payers<\/li>\n<\/ul>\n<\/li>\n<li><strong>Best-practices and case studies for how other pharmaceutical companies are engaging payers<\/strong><\/li>\n<li>Primary <strong>drivers of formulary and reimbursement decisions<\/strong><\/li>\n<li><strong>How and when are payers utilizing RWE<\/strong> (i.e. written report, on a data platform, etc.) and uncovering the need for pharmas to provide this information<\/li>\n<li>Understanding of <strong>beyond the pill programs and payers interest to see patient reported outcomes<\/strong>, and the potential impact on their formulary process or decisions; impact of patient demands<\/li>\n<\/ul>\n<p>\u00a0<\/p>\n","protected":false},"template":"","class_list":["post-160356","report","type-report","status-publish","hentry","report-gateway-digital","digital-study-name-multichannel-payer-marketing","digital-date-941"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/160356","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":10,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/160356\/revisions"}],"predecessor-version":[{"id":575618,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/160356\/revisions\/575618"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=160356"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}